Publications

Recent publications

Forterre A, Komuro H, Aminova S, Harada M. A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies. Cancers (2020) 12(7). DOI: 10.3390/cancers12071852

Wang P, Kim T, Harada M, Contag C, Huang X, Smith BR. Nano-immunoimaging. Nanoscale Horiz. (2020) 5(4):628-653. DOI: 10.1039/C9NH00514E

Lohcharoenkal W, Harada M, Lovén J, Meisgen F, Landén NX, Zhang L, Lapins J, Mahapatra KD, Shi H, Nissinen L, Kähäri VM, Ståhle M, Sonkoly E, Grandér D, Arsenian-Henriksson M, Pivarcsi A., MicroRNA-203 Inversely Correlates with Differentiation Grade, Targets c-MYC, and Functions as a Tumor Suppressor in cSCC. J Invest Dermatol (2016) 136(12):2485-2494. DOI: 10.1016/j.jid.2016.06.630

Harada M., Benito, J., Yamamoto, S., Kaur, S., Arslan, D., Ramirez, S., Jacamo, R., Platanias, L., Matsushita, H., Fujimura, T., Kazuno, S., Kojima, K., Tabe, Y., Konopleva, M., The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression. Oncotarget (2015) Nov 10;6(35):37930-47 DOI: 10.18632/oncotarget.6122

Xu N, Zhang L, Meisgen F, Harada M, Heilborn J, Homey B, Grander D, Stahle M, Sonkoly E, Pivarcsi A., MicroRNA-125b Down-regulates Matrix Metallopeptidase 13 and Inhibits Cutaneous Squamous Cell Carcinoma Cell Proliferation, Migration and Invasion. J Biol Chem. (2012) Jul 10 DOI: 10.1074/jbc.M112.391243

Harada M, Pokrovskaja Tamm K, Soderhall S, Heyman M, Grander D, et al. Involvement of the miR17 pathway in glucocorticoid-induced cell death in pediatric acute lymphoblastic leukemia. Leuk Lymphoma. (2012) DOI: 10.3109/10428194.2012.678004

Google Scholar